<DOC>
	<DOCNO>NCT01703052</DOCNO>
	<brief_summary>This study design investigate safety , tolerability pharmacokinetics inhale CHF 6001 single multiple dos healthy volunteer .</brief_summary>
	<brief_title>Safety Tolerability Inhaled CHF 6001 Healthy Volunteers ( HV )</brief_title>
	<detailed_description>The study conduct single centre consist single dose part multiple dose part . Seven single dos CHF 6001 administer accord escalation , alternate cross scheme . Five multiple dos CHF 6001 administer 7 day accord sequential escalation scheme .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Subject 's write informed consent obtain prior studyrelated procedure Male healthy volunteer age 1855 year ; Able understand study procedure , risk involve ability train use device correctly . Body Mass Index ( BMI ) 18.0 28.0 kg/m2 ; Non exsmokers smoke &lt; 5 pack year ( packyears = number cigarette pack per day time number year ) stop smoke &gt; 1 year ; Results laboratory test within normal range . Minor deviation acceptable provide judge clinically significant investigator . A reliable method contraception subject partner . Blood donation blood loss le 8 week inhalation study medication ; Positive HIV1 HIV2 serology ; Positive result Hepatitis serology indicate acute chronic Hepatitis B Hepatitis C ; History substance abuse drug abuse within 12 month prior screen visit positive urine drug screen screen ; Clinically relevant abnormal laboratory value suggest unknown disease require clinical investigation ; Clinically significant uncontrolled cardiac , hepatic , renal , gastrointestinal , endocrine , metabolic , neurologic , psychiatric disorder may interfere successful completion protocol ; Treatment within previous 3 month drug know well define potential hepatotoxicity ( e.g . isoniazide , nimesulide , ketoconazole ) . Subjects refuse abstain alcohol caffeine contain food beverage grapefruit contain food beverages 48 hour prior intake study medication end confinement clinical centre . Heavy caffeine drinker ( &gt; 5 cup glass caffeinated beverage e.g. , coffee , tea , cola per day ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>